Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Minutia Logo
Minutia Growth Score
75
CB Rank
140128
Heat Score
56
Minutia is a biotech startup that develops cell-based therapies aimed at creating a functional cure for type 1 diabetes.
Founded
obfuscation
PrivateSeries A Oakland, California, United States11-50 minutia.co
Biotechnology
Diabetes
Life Science
Therapeutics
Overview

Minutia
Growth Score
75
Heat Score
56

Growth Score75
-9 pts
in past quarter
Heat Score 56
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Minutia

CB Rank
140128
Minutia is a biotech startup that develops cell-based therapies aimed at creating a functional cure for type 1 diabetes.
Founded
obfuscation
PrivateSeries A Oakland, California, United States11-50 minutia.co
Biotechnology
Diabetes
Life Science
Therapeutics

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name Minutia, LLC
Operating Status Active
Company Type For Profit
Founders  Katy Digovich, Matthias Hebrok, Tuan Vo-Dinh
About the Company
Developing stem cell derived transplants that can communicate transplant status in vivo and are resistant to common transplant challenges, initially focused on enabling a functional cure for Type 1 Diabetes
Diversity Spotlight 
Black Founded
Women Founded
Women Led
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Insulin Producing Cell Transplants with Nanosensors
A cell therapy product combining insulin producing cell transplants with nanosensors for in vivo monitoring in diabetes treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A
obfuscation
Series A - Minutia Logo
Series A - Minutia
2
obfuscation
SOSVSeries A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
SOSV Logo
SOSV
Yes
Series A - Minutia Logo
Series A - Minutia
Po Bronson
SOSV Logo
SOSV
Yes
Series A - Minutia Logo
Series A - Minutia
Po Bronson
SOSV Logo
SOSV
Yes
Series A - Minutia Logo
Series A - Minutia
Po Bronson
SOSV Logo
SOSV
Yes
Series A - Minutia Logo
Series A - Minutia
Po Bronson
SOSV Logo
SOSV
Yes
Series A - Minutia Logo
Series A - Minutia
Po Bronson
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 14

Employee Profiles

News

News and Press

News•Jan 12, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

525
-13.79%
 in past month

IT Spend

$402.4KThis year, Minutia is projected to spend $402.4K on IT, according to Aberdeen.

Active Website Tech Count

2Minutia is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.

Total IP

1Minutia has 1 registered patent in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Minutia's headquarters? Minutia is located in Oakland, California, United States.Who invested in Minutia? Minutia has 2 investors including SOSV and  SOSV SF & NY (Fka IndieBio).When was the last funding round for Minutia? Minutia closed its last funding round on
obfuscation
from a Series A round.Who are Minutia's competitors? Alternatives and possible competitors to Minutia may include Novo Nordisk, Medtronic, and  Evotec.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(0deebd1 1)
|